cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.9254111
title: Additional file 4: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The S-plot proteins that passed the criteria for OPLS-DA modeling and also had a Mann-Whitney U test p-value of less than 0.05. Additional file 4A shows the one protein that passed all three criteria when all stage II and III samples were compared, and Additional file 4B shows the 7 proteins that passed all three criteria when samples from patients with left-sided stage II and III CRC were compared. Additional file 4B shows the 24 proteins that passed all three criteria when samples from patients with stage II and III rectal cancer were compared. Accession, peptide count, unique peptides, confidence score, p-value, fold change, protein name, gene name, covariance (p [1]), and correlation (p (corr) [1]) are given in the tables. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.9254102
title: Additional file 3: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The proteins that passed the cutoff of a Mann-Whitney U test p-value of less than 0.05 in the different groups. Additional file 3A shows the 79 proteins that passed the cutoff when all stage II and III samples were compared. Additional file 3B shows the 97 proteins that passed the cutoff when samples from patients with right-sided stage II and III CRC were compared, and Additional file 3C shows the 38 proteins that passed the cutoff when samples from patients with left-sided stage II and III CRC were compared. Additional file 3D shows the 83 proteins that passed the cutoff when samples from patients with stage II and III rectal cancer were compared. Accession, peptide count, unique peptides, confidence score, p-value, fold change, protein name, and gene name are given in the tables. (XLSX 40 kb)
DOI: 10.6084/m9.figshare.9254111.v1
title: Additional file 4: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The S-plot proteins that passed the criteria for OPLS-DA modeling and also had a Mann-Whitney U test p-value of less than 0.05. Additional file 4A shows the one protein that passed all three criteria when all stage II and III samples were compared, and Additional file 4B shows the 7 proteins that passed all three criteria when samples from patients with left-sided stage II and III CRC were compared. Additional file 4B shows the 24 proteins that passed all three criteria when samples from patients with stage II and III rectal cancer were compared. Accession, peptide count, unique peptides, confidence score, p-value, fold change, protein name, gene name, covariance (p [1]), and correlation (p (corr) [1]) are given in the tables. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.9254099
title: MOESM3 of Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice

description: Additional file 3. A list of identified metabolites and lipids in the cerebral cortex, liver, femoral muscle, and epididymal fat in aged and young mice. Retention time (RT), observed mass (ObsMass), coefficient of variation of mixQC (CV), and ion from lipidomics analysis (Ion) and database identifiers (KEGG and HMDB) for metabolomics analysis are also included in table. Abbreviations: MG, monoacyl; DG, diacylglycerol; TG, triacylglycerol; aa, di-acyl; aaa, tri-acyl; aaaa, tetra-acyl; ae, acyl and ether; phosphatidylcholine, PC; lysophosphatidylcholine, LPC; phosphatidylethanolamine, PE; lysophosphatidylethanolamine, LPE; phosphatidylserine, PS; lysophosphatidylserine, LPS; phosphatidylglycerol, PG; lysophosphatidylglycerol, LPG; phosphatidic acid, PA; lysophosphatidic acid, LPA; phosphatidylinositol, PI; lysophosphatidylinositol, LPI; CL, cardiolipins; Cer, ceramides; SM, sphingomyelins.
DOI: 10.6084/m9.figshare.9254102.v1
title: Additional file 3: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The proteins that passed the cutoff of a Mann-Whitney U test p-value of less than 0.05 in the different groups. Additional file 3A shows the 79 proteins that passed the cutoff when all stage II and III samples were compared. Additional file 3B shows the 97 proteins that passed the cutoff when samples from patients with right-sided stage II and III CRC were compared, and Additional file 3C shows the 38 proteins that passed the cutoff when samples from patients with left-sided stage II and III CRC were compared. Additional file 3D shows the 83 proteins that passed the cutoff when samples from patients with stage II and III rectal cancer were compared. Accession, peptide count, unique peptides, confidence score, p-value, fold change, protein name, and gene name are given in the tables. (XLSX 40 kb)
DOI: 10.6084/m9.figshare.9254096
title: Additional file 1: of The molecular mass and isoelectric point of plant proteomes

description: Supplementary file containing average amino acid composition of plant proteomes. The file is present in excel sheet and individual sheet represents details of different amino acid. (XLSX 252 kb)
DOI: 10.6084/m9.figshare.9254093
title: Additional file 2: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The 224 proteins with two or more unique peptides quantified in this study. This table shows all proteins with two or more unique peptides that were quantified in this study. Accession, peptide count, unique peptides, protein name, gene name, and normalized abundance of each protein in each sample are given in the table. (XLSX 283 kb)
DOI: 10.6084/m9.figshare.9254099.v1
title: MOESM3 of Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice

description: Additional file 3. A list of identified metabolites and lipids in the cerebral cortex, liver, femoral muscle, and epididymal fat in aged and young mice. Retention time (RT), observed mass (ObsMass), coefficient of variation of mixQC (CV), and ion from lipidomics analysis (Ion) and database identifiers (KEGG and HMDB) for metabolomics analysis are also included in table. Abbreviations: MG, monoacyl; DG, diacylglycerol; TG, triacylglycerol; aa, di-acyl; aaa, tri-acyl; aaaa, tetra-acyl; ae, acyl and ether; phosphatidylcholine, PC; lysophosphatidylcholine, LPC; phosphatidylethanolamine, PE; lysophosphatidylethanolamine, LPE; phosphatidylserine, PS; lysophosphatidylserine, LPS; phosphatidylglycerol, PG; lysophosphatidylglycerol, LPG; phosphatidic acid, PA; lysophosphatidic acid, LPA; phosphatidylinositol, PI; lysophosphatidylinositol, LPI; CL, cardiolipins; Cer, ceramides; SM, sphingomyelins.
DOI: 10.6084/m9.figshare.9254096.v1
title: Additional file 1: of The molecular mass and isoelectric point of plant proteomes

description: Supplementary file containing average amino acid composition of plant proteomes. The file is present in excel sheet and individual sheet represents details of different amino acid. (XLSX 252 kb)
DOI: 10.6084/m9.figshare.9254087
title: Additional file 1: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: Information about the colorectal cancer patients included in this study. The table shows patients’ gender, age at operation, tumor stage, location, and sample code. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.9254093.v1
title: Additional file 2: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The 224 proteins with two or more unique peptides quantified in this study. This table shows all proteins with two or more unique peptides that were quantified in this study. Accession, peptide count, unique peptides, protein name, gene name, and normalized abundance of each protein in each sample are given in the table. (XLSX 283 kb)
DOI: 10.6084/m9.figshare.9254078
title: Additional file 11 of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The proteins whose levels differed between samples from patients with stage II and III CRC in two primary tumor locations. Additional file 11A shows the 33 proteins whose levels differed between stage II and III samples from patients with cancer in the right colon and rectum, Additional file 11B shows the 7 proteins whose levels differed between stage II and III samples from patients with cancer in the right and left colon, and Additional file 11C shows the 7 proteins whose levels differed between stage II and III samples from patients with cancer in the left colon and rectum. Accession, peptide count, unique peptides, confidence score, protein name, and gene name are given in the tables. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.9254084
title: MOESM1 of Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice

description: Additional file 1. Plasma biochemical parameters. Glucose (Glu), triglyceride (TG), glutamic pyruvic transaminase (GPT), total cholesterol (T-CHO), and total ketone body (T-KB) levels; body weights; and weight reduction rates (%).
DOI: 10.6084/m9.figshare.9254087.v1
title: Additional file 1: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: Information about the colorectal cancer patients included in this study. The table shows patients’ gender, age at operation, tumor stage, location, and sample code. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.9254084.v1
title: MOESM1 of Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice

description: Additional file 1. Plasma biochemical parameters. Glucose (Glu), triglyceride (TG), glutamic pyruvic transaminase (GPT), total cholesterol (T-CHO), and total ketone body (T-KB) levels; body weights; and weight reduction rates (%).
DOI: 10.6084/m9.figshare.9254078.v1
title: Additional file 11 of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The proteins whose levels differed between samples from patients with stage II and III CRC in two primary tumor locations. Additional file 11A shows the 33 proteins whose levels differed between stage II and III samples from patients with cancer in the right colon and rectum, Additional file 11B shows the 7 proteins whose levels differed between stage II and III samples from patients with cancer in the right and left colon, and Additional file 11C shows the 7 proteins whose levels differed between stage II and III samples from patients with cancer in the left colon and rectum. Accession, peptide count, unique peptides, confidence score, protein name, and gene name are given in the tables. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.9254072
title: Additional file 10: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The proteins whose levels differed between samples from patients with stage II and III CRC in one primary tumor location only. Additional file 10A shows the 44 proteins whose levels differed between stage II and III samples from patients with right-sided CRC only, Additional file 10B shows the 11 proteins whose levels differed between stage II and III samples from patients with left-sided CRC only, and Additional file 10C shows the 30 proteins whose levels differed between stage II and III samples from patients with rectal cancer only. Accession, peptide count, unique peptides, confidence score, protein name, and gene name are given in the tables. (XLSX 16 kb)
DOI: 10.6084/m9.figshare.9254072.v1
title: Additional file 10: of Differences and overlap in plasma protein expression during colorectal cancer progression

description: The proteins whose levels differed between samples from patients with stage II and III CRC in one primary tumor location only. Additional file 10A shows the 44 proteins whose levels differed between stage II and III samples from patients with right-sided CRC only, Additional file 10B shows the 11 proteins whose levels differed between stage II and III samples from patients with left-sided CRC only, and Additional file 10C shows the 30 proteins whose levels differed between stage II and III samples from patients with rectal cancer only. Accession, peptide count, unique peptides, confidence score, protein name, and gene name are given in the tables. (XLSX 16 kb)
DOI: 10.6084/m9.figshare.9253964
title: Additional file 1: of A systematic review of cases of meningitis in the absence of cerebrospinal fluid pleocytosis on lumbar puncture

description: Summary table of patient age, gender, CSF results, blood cultures and outcome [58]. (XLSX 35 kb)
DOI: 10.6084/m9.figshare.9253964.v1
title: Additional file 1: of A systematic review of cases of meningitis in the absence of cerebrospinal fluid pleocytosis on lumbar puncture

description: Summary table of patient age, gender, CSF results, blood cultures and outcome [58]. (XLSX 35 kb)
DOI: 10.6084/m9.figshare.9253946
title: Additional file 9: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. TATE copies analyzed in all species are provided together with the flanking region (TXT 2700 kb)
DOI: 10.6084/m9.figshare.9253940
title: Additional file 8: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. VIPER copies analyzed in all species are provided together with the flanking region (TXT 2890 kb)
DOI: 10.6084/m9.figshare.9253946.v1
title: Additional file 9: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. TATE copies analyzed in all species are provided together with the flanking region (TXT 2700 kb)
DOI: 10.6084/m9.figshare.9253940.v1
title: Additional file 8: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. VIPER copies analyzed in all species are provided together with the flanking region (TXT 2890 kb)
DOI: 10.6084/m9.figshare.9253880
title: Additional file 2: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Table. Summary of the analyzes of the 15 most conserved copies of VIPER and TATE elements in each species. (XLSX 98 kb)
DOI: 10.6084/m9.figshare.9253880.v1
title: Additional file 2: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Table. Summary of the analyzes of the 15 most conserved copies of VIPER and TATE elements in each species. (XLSX 98 kb)
DOI: 10.6084/m9.figshare.9253865
title: Additional file 18: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments . Alignment of YR sequences of DIRS retrotransposons (DIRS-like, PAT-like, Ngaro-like, and VIPER-like) along with other YR family proteins (FAS 23 kb)
DOI: 10.6084/m9.figshare.9253862
title: Additional file 17: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments . Alignment of RH sequences of different groups of retroelements (FAS 17 kb)
DOI: 10.6084/m9.figshare.9253862.v1
title: Additional file 17: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments . Alignment of RH sequences of different groups of retroelements (FAS 17 kb)
DOI: 10.6084/m9.figshare.9253865.v1
title: Additional file 18: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments . Alignment of YR sequences of DIRS retrotransposons (DIRS-like, PAT-like, Ngaro-like, and VIPER-like) along with other YR family proteins (FAS 23 kb)
DOI: 10.6084/m9.figshare.9253856
title: Additional file 16: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments. Alignment of RT sequences of different groups of retroelements (FAS 24 kb)
DOI: 10.6084/m9.figshare.9253856.v1
title: Additional file 16: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments. Alignment of RT sequences of different groups of retroelements (FAS 24 kb)
DOI: 10.6084/m9.figshare.9253841
title: Additional file 13: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments. Alignment of YR sequences of VIPER and TATE (FAS 15 kb)
DOI: 10.6084/m9.figshare.9253835
title: Additional file 12: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments. Alignment of RT/RH sequences of VIPER and TATE (FAS 30 kb)
DOI: 10.6084/m9.figshare.9253841.v1
title: Additional file 13: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments. Alignment of YR sequences of VIPER and TATE (FAS 15 kb)
DOI: 10.6084/m9.figshare.9253835.v1
title: Additional file 12: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Alignments. Alignment of RT/RH sequences of VIPER and TATE (FAS 30 kb)
DOI: 10.6084/m9.figshare.9253823
title: Additional file 11: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. Putative complete TATE copies (TXT 31 kb)
DOI: 10.6084/m9.figshare.9253817
title: Additional file 10: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. Putative complete VIPER copies (TXT 52 kb)
DOI: 10.6084/m9.figshare.9253823.v1
title: Additional file 11: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. Putative complete TATE copies (TXT 31 kb)
DOI: 10.6084/m9.figshare.9253811
title: Additional file 6: of Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)

description: Observed versus predicted HSUVs by severity. (XLSX 359 kb)
DOI: 10.6084/m9.figshare.9253817.v1
title: Additional file 10: of Study of VIPER and TATE in kinetoplastids and the evolution of tyrosine recombinase retrotransposons

description: Sequences. Putative complete VIPER copies (TXT 52 kb)
DOI: 10.6084/m9.figshare.9253811.v1
title: Additional file 6: of Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)

description: Observed versus predicted HSUVs by severity. (XLSX 359 kb)
DOI: 10.6084/m9.figshare.9253796
title: Additional file 4: of Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)

description: All model results. (XLSX 52 kb)
DOI: 10.6084/m9.figshare.9253793
title: Additional files 4: of Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms

description: Description of data: average GO similarity distance scores of intra-cluster, inter-cluster, and difference between intra-cluster and inter-cluster in each algorithm in each cancer type. (ZIP 8 kb)
DOI: 10.6084/m9.figshare.9253796.v1
title: Additional file 4: of Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)

description: All model results. (XLSX 52 kb)
DOI: 10.6084/m9.figshare.9253784
title: Additional files 3: of Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms

description: Description of data: the graphs describe the change of cluster numbers and mathematical condition satisfactions as more merging rounds are applied to different cancer types by MWMM approach. The supplementary graphs have the same setting as Figs.Â 17 and 23 in the context. (ZIP 62 kb)
DOI: 10.6084/m9.figshare.9253775
title: Additional files 2: of Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms

description: Description of data: inner weight, emitter to matched receiver outer weight, receiver to matched emitter outer weight, condition 01, and condition 02 of each cluster derived from a specific algorithm in the MWMM approach. (ZIP 18 kb)
DOI: 10.6084/m9.figshare.9253784.v1
title: Additional files 3: of Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms

description: Description of data: the graphs describe the change of cluster numbers and mathematical condition satisfactions as more merging rounds are applied to different cancer types by MWMM approach. The supplementary graphs have the same setting as Figs.Â 17 and 23 in the context. (ZIP 62 kb)
DOI: 10.6084/m9.figshare.9253766
title: Additional file 2: of Awareness of diabetes and diabetic retinopathy among a group of diabetic patients in main public hospitals in Damascus, Syria during the Syrian crisis

description: The manuscript data: it contains raw data of our results. (XLSX 51 kb)
DOI: 10.6084/m9.figshare.9253769
title: Additional files 1: of Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms

description: Description of data: top 38 edge-weighted miRNA-mRNA pairs of all six edge weight formulas clustered by traditional hierarchical clustering algorithm are shown in the graphs. (ZIP 39 kb)
DOI: 10.6084/m9.figshare.9253766.v1
title: Additional file 2: of Awareness of diabetes and diabetic retinopathy among a group of diabetic patients in main public hospitals in Damascus, Syria during the Syrian crisis

description: The manuscript data: it contains raw data of our results. (XLSX 51 kb)
DOI: 10.6084/m9.figshare.9253769.v1
title: Additional files 1: of Clustering analysis of microRNA and mRNA expression data from TCGA using maximum edge-weighted matching algorithms

description: Description of data: top 38 edge-weighted miRNA-mRNA pairs of all six edge weight formulas clustered by traditional hierarchical clustering algorithm are shown in the graphs. (ZIP 39 kb)
DOI: 10.6084/m9.figshare.9253640
title: Randomized controlled trial of a water-soluble formulation of lutein in humans

description: Lutein is poorly absorbed owing to their high hydrophobicity and crystallinity. This double-blind crossover trial involved eight healthy males who were administrated capsules containing either a lutein water-soluble formulation or a lutein oil suspension for 8 days. In the formulation group, plasma and erythrocytes lutein concentrations and baseline-corrected AUC were two-fold higher than those in the oil suspension group.
DOI: 10.6084/m9.figshare.9253640.v1
title: Randomized controlled trial of a water-soluble formulation of lutein in humans

description: Lutein is poorly absorbed owing to their high hydrophobicity and crystallinity. This double-blind crossover trial involved eight healthy males who were administrated capsules containing either a lutein water-soluble formulation or a lutein oil suspension for 8 days. In the formulation group, plasma and erythrocytes lutein concentrations and baseline-corrected AUC were two-fold higher than those in the oil suspension group.